MRNA LONG
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). And recently we have seen it fall back to a very cheap price than it was back in 2 August 2021, In its current position we look to buy shares on MRNA as it is currently in a demand level.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。